Article
Pyrosequencing analysis of EGFR and KRAS mutations in EUS and EBUS-derived cytologic samples of adenocarcinomas of the lung.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Aug 2013
Stigt Jos A, 'tHart Nils A, Knol Ageeth J, Uil Steven M, Groen Harry J M
Abstract excerpt
INTRODUCTION: Patients with stage IV non-small-cell lung cancer harboring an activating epidermal growth factor receptor (EGFR) mutation are eligible for treatment with EGFR tyrosine kinase inhibitors. With pyrosequencing, low-frequency mutations may be detected more easily even in small diagnostic samples like endoscopic ultrasound-guided fine needle aspirations (EUS-FNA) and endobronchial ultrasound-guided...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
